[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fhBGvLHMPL9O1rh2RTewfFsBu9COsgrhwaTf4uI28W2M":3},{"answer":4,"createTime":5,"id":6,"options":7,"origin":13,"question":20,"related":21,"source":33,"type":34},[],"2023-12-25 16:05:15",121314353,[8,9,10,11,12],"C3~C9","C1~C9","C5~C9","C1~C4","C1、C2、C4",{"count":14,"courseId":15,"courseImg":16,"courseName":17,"workId":18,"workName":19},45,"efd77d9400f449c7f6c7e8dd3e1cd3c6","https:\u002F\u002Ftihai-oss-cloud.itihey.com\u002Fimg\u002F4dbf347d0836be8909524c26223d7a64.jpg","【23秋】医学免疫学（1）","fec929baf3204ea8813c9a834c71d9b7","补体系统(单选题)","以下参与旁路激活途径的补体成分是",[22,35,45,55,65,74,82,87,93,103],{"answer":23,"createTime":24,"id":25,"options":26,"question":32,"source":33,"type":34},[],"2023-12-25 16:05:14",121314337,[27,28,29,30,31],"IgG","IgM","IgD","LPS","MBL","参与旁路途径激活补体的物质是","v1",0,{"answer":36,"createTime":24,"id":37,"options":38,"question":44,"source":33,"type":34},[],121314339,[39,40,41,42,43],"诱导免疫耐受","抑制超敏反应","裂解细菌","启动抗体的类别转换","结合细胞毒性T细胞","补体系统在激活后可以",{"answer":46,"createTime":24,"id":47,"options":48,"question":54,"source":33,"type":34},[],121314341,[49,50,51,52,53],"C2b","C3b","C5b","C2a","C4a","具有调理吞噬作用的补体裂解产物是",{"answer":56,"createTime":24,"id":57,"options":58,"question":64,"source":33,"type":34},[],121314345,[59,60,61,62,63],"C3","C5","C1","C4","C9","补体固有成分中分子量最大的是",{"answer":66,"createTime":5,"id":67,"options":68,"question":73,"source":33,"type":34},[],121314346,[69,70,71,62,72],"C1q","C1r","C1s","C2","在经典激活途径中,补体的识别单位是",{"answer":75,"createTime":5,"id":76,"options":77,"question":81,"source":33,"type":34},[],121314347,[69,78,59,79,80],"C4和C2","B因子","D因子","同时参与补体三种激活途径的成分是",{"answer":83,"createTime":5,"id":84,"options":85,"question":86,"source":33,"type":34},[],121314350,[61,63,79,59,60],"血清中含量最高的补体固有成分是",{"answer":88,"createTime":5,"id":89,"options":90,"question":92,"source":33,"type":34},[],121314351,[80,79,61,59,91],"P因子","以下不参与旁路激活途径的是",{"answer":94,"createTime":5,"id":95,"options":96,"question":102,"source":33,"type":34},[],121314352,[97,98,99,100,101],"三条途径的膜攻击复合物相同","旁路途径在感染后期发挥作用","经典途径从C1激活开始","旁路途径从C3激活开始","MBL途径中形成的C3转化酶是C4b2a","关于补体三条激活途径描述错误的是",{"answer":104,"createTime":5,"id":6,"options":105,"question":20,"source":33,"type":34},[],[8,9,10,11,12]]